Related Experiment Videos
Paraproteins in primary biliary cirrhosis
The Quarterly Journal of Medicine
|July 1, 1986
Summary
Paraproteins are rarely seen in primary biliary cirrhosis (PBC). This study identified 18 patients with both antimitochondrial antibodies and paraproteins, suggesting a potential link between these conditions.
Area of Science:
- Immunology
- Hepatology
- Oncology
Background:
- Paraproteins are uncommon in primary biliary cirrhosis (PBC).
- Antimitochondrial antibodies (AMAs) are a hallmark of PBC.
- The co-occurrence of paraproteins and AMAs requires further investigation.
Purpose of the Study:
- To investigate the prevalence and characteristics of paraproteins in patients with AMAs.
- To explore the relationship between paraproteins and primary biliary cirrhosis.
Main Methods:
- Screening of 950 patients with known paraproteins or documented AMAs.
- Clinical assessment of patients with co-existing paraproteins and AMAs.
- Analysis of AMA subclass distribution and immunoglobulin levels.
Main Results:
- Eighteen patients (1.9%) were identified with both AMAs and significant paraproteins.
- Eleven patients had proven or probable PBC, and five had plasma dyscrasia (two with co-existing PBC).
- AMA activity was polyclonal and IgG3 subclass predominant in PBC patients, with normal levels; other patients showed no subclass restriction and lowered IgG3 levels.
Conclusions:
- Paraproteins can occur in patients with AMAs, sometimes alongside PBC.
- AMA subclass distribution differs between PBC patients with paraproteins and those without.
- Further research is needed to understand the clinical significance of paraproteins in AMA-positive individuals.